Whitworth, Pat
Beitsch, Peter D.
Pellicane, James V.
Baron, Paul L.
Lee, Laura A.
Dul, Carrie L.
Nash, Charles H. III
Murray, Mary K.
Richards, Paul D.
Gittleman, Mark
Budway, Raye
Rahman, Rakhshanda Layeequr
Kelemen, Pond
Dooley, William C.
Rock, David T.
Cowan, Ken
Lesnikoski, Beth-Ann
Barone, Julie L.
Ashikari, Andrew Y.
Dupree, Beth
Wang, Shiyu
Menicucci, Andrea R.
Yoder, Erin B.
Finn, Christine
Corcoran, Kate
Blumencranz, Lisa E.
Audeh, William
,
Article History
Received: 11 October 2021
Accepted: 7 March 2022
First Online: 4 April 2022
Disclosure
: PW, WCD, KC, CHN, PDR, and BL have contracted research with Agendia Inc. PW serves on the advisory board of Medtronic, Lumicell, ImpediMed, Cianna Medical, Prelude, and Bard Bard; has contracted research with Invitae, Intact, and Prelude; has ownership interests in Targeted Medical Education, Reverse Medical, Rebound Medical, Lazarus, Cerebrotech, and Medneon; receives honoraria from Medtronic; and has received travel/accommodations from ImpediMed. JVP receives honoraria as part of the Speaker’s Bureau for Agendia Inc. WCD has ownership interests in Shaga Medical, LLC. SW, ARM, EBY, CF, KC, LEB, and WA are non-commercial employees of Agendia Inc. No other disclosures have been reported.